Mortality in Barrett's esophagus: three decades of experience at a single center
- PMID: 22752886
- DOI: 10.1055/s-0032-1309842
Mortality in Barrett's esophagus: three decades of experience at a single center
Abstract
Background and study aims: There is a view that the majority of deaths in patients with Barrett's esophagus are from causes other than esophageal adenocarcinoma (EAC). The aim of this analysis was to establish the pattern of mortality for a number of causes in patients with Barrett's esophagus.
Patients and methods: This was a single-center prospective cohort study of patients from Rotherham District General Hospital, which is a secondary referral center. The cohort consisted of 1239 patients who were diagnosed with Barrett's esophagus between April 1978 and March 2009. Follow-up for mortality was undertaken by "flagging" the patients with the NHS Information Center. Causes of death were compared with UK Office of National Statistics age- and sex-specific mortality data for 1999, the median year of diagnosis. Analysis was by a "person - years at risk" calculation from date of diagnosis.
Results: The ratio of observed deaths from EAC compared with those expected in this cohort was 25.02 - a very large excess. There was no difference in mortality from colorectal cancer or circulatory disease and there were fewer deaths from cancers other than esophageal adenocarcinoma and colon cancer compared with national statistics. There was a small statistically significant difference in mortality from all causes but this disappeared completely when deaths from esophageal adenocarcinoma were excluded.
Conclusions: Overall, mortality in Barrett's esophagus is increased significantly but only as a result of the large excess of deaths from EAC. This strengthens the case for endoscopic surveillance if successful interventions can be undertaken in patients with Barrett's esophagus to prevent development of esophageal adenocarcinoma.
© Georg Thieme Verlag KG Stuttgart · New York.
Comment in
-
[Comment on Caygill et al].Endoscopy. 2012 Oct;44(10):988. Endoscopy. 2012. PMID: 23162830 French. No abstract available.
-
Barrett's esophagus as a marker for increased risk for esophageal cancer and cardiorespiratory disease.Endoscopy. 2013;45(2):152. doi: 10.1055/s-0032-1325964. Epub 2013 Jan 30. Endoscopy. 2013. PMID: 23364842 No abstract available.
-
Reply to Schoppman et al.Endoscopy. 2013;45(2):153. doi: 10.1055/s-0032-1326102. Epub 2013 Jan 30. Endoscopy. 2013. PMID: 23364843 No abstract available.
Similar articles
-
Barrett's surveillance identifies patients with early esophageal adenocarcinoma.Am J Med. 2010 May;123(5):462-7. doi: 10.1016/j.amjmed.2009.10.013. Am J Med. 2010. PMID: 20399324
-
The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.Am J Gastroenterol. 1998 Apr;93(4):536-41. doi: 10.1111/j.1572-0241.1998.161_b.x. Am J Gastroenterol. 1998. PMID: 9576444
-
[Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].Chir Ital. 2002 Sep-Oct;54(5):591-6. Chir Ital. 2002. PMID: 12469454 Italian.
-
Treatment of Barrett's esophagus with high-grade dysplasia.Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Expert Rev Anticancer Ther. 2009. PMID: 19275509 Review.
-
[Surgical treatment of adenocarcinoma in Barrett's esophagus and prognosis].Nihon Geka Gakkai Zasshi. 1999 Mar;100(3):257-60. Nihon Geka Gakkai Zasshi. 1999. PMID: 10379536 Review. Japanese.
Cited by
-
Is Malignant Potential of Barrett's Esophagus Predictable by Endoscopy Findings?Life (Basel). 2020 Oct 16;10(10):244. doi: 10.3390/life10100244. Life (Basel). 2020. PMID: 33081277 Free PMC article. Review.
-
Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.J Gastroenterol. 2019 Nov;54(11):984-993. doi: 10.1007/s00535-019-01600-x. Epub 2019 Jun 25. J Gastroenterol. 2019. PMID: 31240437
-
Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.World J Gastroenterol. 2014 Jul 28;20(28):9611-7. doi: 10.3748/wjg.v20.i28.9611. World J Gastroenterol. 2014. PMID: 25071359 Free PMC article.
-
Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett's esophagus.Clin Epigenetics. 2024 Dec 19;16(1):184. doi: 10.1186/s13148-024-01801-z. Clin Epigenetics. 2024. PMID: 39702397 Free PMC article.
-
Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.United European Gastroenterol J. 2016 Jun;4(3):343-52. doi: 10.1177/2050640615612409. Epub 2015 Oct 30. United European Gastroenterol J. 2016. PMID: 27403300 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous